Histone Deacetylase Inhibitor [EPC]: Side Effects & Safety Data for 3 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Histone Deacetylase Inhibitor [EPC] includes 3 drugs with a combined 1,816 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
3
Drugs in Class
1,816
Combined Reports
All Histone Deacetylase Inhibitor [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| VORINOSTAT | ZOLINZA | 1,246 | 239 | 490 | 19.2% |
| BELINOSTAT | Beleodaq | 305 | 103 | 123 | 33.8% |
| GIVINOSTAT | DUVYZAT | 265 | 5 | 17 | 1.9% |
Common Side Effects in Histone Deacetylase Inhibitor [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Febrile neutropenia | 183 | 27 |
| Platelet count decreased | 163 | 22 |
| Nausea | 136 | 23 |
| Diarrhoea | 134 | 17 |
| Thrombocytopenia | 123 | 22 |
| Product use in unapproved indication | 122 | 16 |
| Off label use | 112 | 20 |
| Vomiting | 110 | 16 |
| Anaemia | 108 | 21 |
| Disease progression | 100 | 57 |